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Summary: Fourteen patients with Borrelia burgdorferi infection were investigated for possible abnormalities of
tryptophan and neopterin metabolism. Four patients (2 were investigated before therapy, 2 when therapy had been
already started) had acute Lyme neuroborreliosis, and 10 patients were investigated months to years after an acute
infection. Increased concentrations of neopterin and of the tryptophan-degradation product, ,-kynurenine, were
detected in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis; one patient presented with subnor-
mal tryptophan. Similar but less marked changes were seen in the treated patients and in some of the patients with
Lyme encephalopathy. No such abnormalities were seen in the serum of the patients. The data indicate a role of the
immune System and particulary of endogenously formed cytokines, like interferon- and tumour necrosis factor-a,
effecting tryptophan and neopterin metabolism in patients with acute Lyme neuroborreliosis.
Introduction
The tick-borne spirochaete, Borrelia burgdorferi, is the
aetiological agent of Lyme borreliosis, a disease, which
may also affect the nervous System. In the acute dissem-
inated phase, meningitis, cranial neuritis and radiculo-
neuritis represent a typical triad of clinical manifesta-
tion. These Symptoms respond rapidly to antibiotic ther-
apy (1). Whether ongoing infection or öther mechanisms
cause chronic neurologic manifestations after adequate
antibiotic therapy is still unclear.
Specific T- and B-dymphocyte respönses'have been de-
monstrated in humans (2) after infection with B, burg-
dorferi. Increased neopterin and Z^kynurenine concen-
trations in the cerebrospinal flüid of patients with Lyme
neuroborreliosis have been described recently (3, 4).
These data indicate a eellular immune response and in-
trathecal release of interferon- in patients. Interferon-
strongly induces activation of GTP cyclohydrolase I and
formation of neopterin in human monocytes/macro-
phages (5). Likewise, indoleamine (2,3)-dioxygenase is
stimulated by interferon- in human monocytes/macro-
phages and in a variety of other cells and cell lines
(6—8). The induction of GTP cyclohydrolase I and indo-
leamine (2,3)-dioxygenase by interferon- is enhanced
by tumour necrosis factor-a (8).
In the present study, we compared tryptophan metabo-
lism (i. e. changes in tryptophan and kynurenine concen-
trations) with neopterin levels in 4 patients with acute
neuroborreliosis and in 10 patients months to years after
the acute stage of the illness.
Patients and Methods
Patients
Fourteen serum and 13 cerebrospinal fluid samples were investi-
gated from 4 patients with acute neuroborreliosis and 10 patients
months to years after the acute stage of the illness. The patients
(cJ/$ ratio 6/8, median age 61, ränge 28-70 years at time of sample
collection) were diagnosed and treated between 1983 and 1992 at
the Neurological Department, University of Innsbruck. Samples
were taken trom acute infection patients l and 2 before the com-
mencement of antibiotic therapy, and from acute infection patients
3 and 4 after the commencement of antibiotic therapy (tab. l). Ten
patients were investigated months to years (median 41, ränge 11 -
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106 months) after antibiotic therapy. These patients were part of
an earlier evaluation of 20 patients with Lyme encephalopathy (9),
who agreed io a spinal tap for cerebrospinal fluid collection. In one
of these patients a spinal tap was not possible because of massive
degenerative vertebral changes.
Concentrations of analytes were compared with normal ranges
from earlier studies (tab. 2). As an additional control, serum from
20 healthy blood donors, 19-61 years of age, was included, be-
cause serum tryptophan and kynurenine coneentrations in an earlier
study (10) were obtained with a slightly different high-performance
liquid Chromatographie method.
Methods
Samples were stored at -20 °C until measurement. Neopterin con-
eentrations were quantified by radioimmunoassay (IMMUtest
Neopterin, Henning-Berlin, Berlin, Germany). Tryptophan and L-
kynurenine concentrations were quantified using high-performance
liquid chromatography with on-line deproteinization of serum and
cerebrospinal fluid samples (10, 11). Separation was performed on
reversed phase C18 material (LiChroCart, Merck, Darmstadt, Ger-
many) injecting 100 μΐ of sample via an advanced autosampling
device (AASP, Varian, Palo Alto, California) using solid-phase ex-
traction on cartridges (SCX, Varian) before liquid chromatography
(10). Kynurenine was monitored by its ultraviolet absorption at 360
nm, tryptophan by fluorescence detection at 365 nm emission and
285 nm excitation wavelengths. The limits of detection were 0. l
μηιοΐ/ΐ kynurenine (signal/noise ratio of 5/1), 0.2 μπιοΙ/1 tryptophan
(signal/noise ratio of 5/1) and 3 nmol/1 neopterin.
For statistical evaluation we used non-parametric methods, namely
the Mann-Wtiitney U-test for comparison between groups and the
Spearman rank correlation analyses to analyse associations be-
tween analyte concentrations.
Results
In the diagnosis of Lyme neuroborreliosis, eight of the
14 patients showed the typical triad of neurological
manifestations - meningitis, cranial ne ritis (seven uni-
or bilateral facial nerve palsy, one bilateral hypoacusis)
and radiculoneuritis, four suffered froin meningitis and
radiculoneuritis, one from meningitis and cranial ne ri-
tis (right abducens paralysis) and one from cranial ne ri-
tis (bilateral abducens paralysis and hypoacusis, right fa-
cial nerve palsy) without meningitis. Six patients had a
history of erythema migrans. Cerebrospinal fluid inves-
tigations displayed lymphocytic-predominant pleo-
cytosis in 13 patients (median cell counts 110, r nge
8-357 X 106/1) and elevated protein (median 1.29,
r nge 0.70-5.58 g/l) in 12 of 13 patients. In nine pa-
tients intrathecal B. burgdorferi antibody production
and/or B. burgdorferi specific oligoclonal antibodies
were determined; one showed no sign of intrathecal anti-
body production (tab. 1). In this case neuroborreliosis
was clinically diagnosed (typical triad of neurologic
manifestations, arthralgias and immediate recovery after
antibiotic treatment). In five patients, the ratio of in-
trathecal B. burgdorferi-specific antibody production
versus serurn titres was not determined: on case with
radiculoneuritis and lyniphocytic meningitis and a B.
burgdorferi IgG-titre in cerebrospinal fluid > l : 256
(immunofluorescence test), one case with lymphocytic
meningitis, radiculitic pain, bilateral facial palsy and
positive B. burgdorferi serum IgG-titre (l : 256) and
IgM-titre (l : 64) one year after onset of clinical Symp-
toms (at first misdiagnosed s meningeal tuberculosis),
one case with cranial ne ritis Without menigitis, serum
IgG-titre l : 64 and IgM-titre l : 128, two cases with
meningitis and radiculoneuritis and positive IgG in cere-
brospinal fluid (l case ELISA, l immunofluorescence
test; titre was not determined). Overall durati of
neurologic manifestations varied according to the time
of diagnosis and treatment. Mean duration of irivolve-
ment was 5 weeks (3 to 9 weeks); however, five patients
had a much longer acute stage (3 to 12 months, mean
7.8 months). Nine patients (see from 1990 to 1992)
were treated with 2 g ceftriaxone for 14 days, f ur (seen
from 1983 to 1987) received iiitravenous penicillin, 20
million units a day in a devided dose for ten days, arid
one was treated with tetracyclin, 2000 mg a day, after
developing an allergic reaction to penicillin.
At the time of sample collection for this evaluation, ce-
rebrospinal fluid investigations of the four patients with
acute illness (two before, two after onset of antibiotic
treatment) displayed a lymphocytic pleocytosis and pro-
tein elevation (mean cell counts 86, r nge 25—245
X 106/1; mean protein 0.87, r nge 0.52-1.22 g/l). Eight
of nine cerebrospinal fluid investigations out of the
Lyme encephalopathy group were normal, and one
showed a mild protein elevation (0.59 g/l). CHnie l f l-
low-up of these ten patients revealed residual Symptoms
in four cases (rnild right facial nerve palsy, mild radicu-
lar Symptoms, mild radicular Symptoms and right facial
nerve palsy, bilateral abducens paralysis and hypoa-
cusis).
In 20 healthy controls, serum concentrations of
neopterin (mean ± S. D.: 5.2 ± 1.79 nmol/1), tryptophan
(89.2 ± 15.6 μπιοΐ/ΐ) and kynurenine (2.1 ± 0.49
μπιοΙ/1) agreed well with the normal r nge found in
earlier studies which, however, was determined with a
slighly different high-performance liquid chromatogra-
phy method. The kynurenine : tryptophan ratio was
24.4 ± 7.4.
In patients with acute Lyme neuroborreliosis a coinci-
dental increase of the neopterin and kynurenine concen-
trations was observed, which was pronounced in eere-
brospinal fluid but not iii the serum of patients. All pa-
tients with acute Lyme neuroborreliosis and most pa-
tients with late Lyme encephalbpatby had normal serum
concentrations of neopterin (elevated in 2/10 patients in
the latter group) and kynurenine (elevated in 1/9 patients
in the latter group; tab. 2). Tryptophan concentrations in
serum were below normal ia 2/4 patients with acute
Lyrne neuroborreliosis (bothMintreated patients) and in
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Durations of Symptoms (weeks)
Meningitis, cranial neuritis and radiculoneuritis






speciflc oligoclonal antibody production
Cerebrospinal fluid cell counts (106/1)
Cerebrospinal fluid protein (g/l)
+ = present — = absent nd = not determined
, * = case 1 1 suffered from cranial neuritis without
1 2 3 4 5 6
64 35 28 35 62 64
9 9 ? $ 9 cJ
5 5 48 3 9 12
+ + + + + -
- - - - - -
- - - - - +
+ - - + + -
- - + + - nd
-f nd + + + nd
245 25 309 110 187 16
1.2 0.7 5.6 1.3 1.0 1.3
meningitis
Tab. 2 Results of measurements in serum and Cerebrospinal fluid and of patients





























































10 11 12 13 14
62 64 29 64 54
9 9 < ? < ? < ?
5 28 5 20 5
+ - _ _ _
_ * _ _ _
- - + + +
-l· - + - -
4- nd + nd nd
nd nd nd nd nd
192 1 193 8 51
1.7 0.5 0.8 1.3 2.0








































nd = not determined
* = below detection limit; for statistical evaluation these values were calculated s zero
4/9 patients with late Lyme encephalopathy. In contrast,
in Cerebrospinal fluid samples, 3/4 patients with acute
Lyme neuroborreliosis had iricreased neopterin concen-
trations (l treated patient had neopterin within the nor-
mal r nge). Concentrations of kynurenine behaved simi-
larly (3 patients with elevated kynurenine concentra-
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tions, l treated patient with normal kynurenine). The
patient with the highest neopterin concentration showed
a subnormal concentration of tryptophan, despite this
fact the kynurenine concentration was high. Taking into
consideration the low tryptophan concentration in cere-
brospinal fluid, the relative amount of kynurenine was
by far the highest in patient 3 (kynurenine per trypto-
phan ratio = 2000), followed by patient l (ratio: 1000),
which mirrors exactly the magnitude of neopterin levels
in cerebrospinal fluid of the same patients (tab. 2).
A significant correlation existed between neopterin con-
centrations and mononuclear cell count in cerebrospinal
fluid (rs = 0.625, p = 0.030). Similar and signifieant
correlations were found between the concentrations of
neopterin and kynurenine and the kynurenine : trypto-
phan ratio; the correlations were strongest between
neopterin and kynurenine in cerebrospinal fluid:
rs = 0.871, p = 0.0031 in all patients; rs = 0.743,
p = 0.036 in patients with late Lyme encephalopathy
only (fig'.^l). Although most patients with late Lyme en-
cephalopathy had normal neopterin (1/9 elevated) and
kynurenine (2/9 detectable 4 elevated), and all had nor-
mal tryptophan concentrations in the cerebrospinal fluid,
there is still a similar degree of correlation between the
concentrations of kynurenine and neopterin (flg. 1).
Concentration changes in patient sera were only mar-
ginal compared with those in cerebrospinal fluid, but
average serum tryptophan concentrations were signifi-
cantly decreased in patients (n = 13: 59.0 ± 11.0
μπιοΐ/ΐ) compared with the group of healthy controls







Fig. l Correlation between concentrations of neopterin and ky-
nurenine in cerebrospinal fluid of patients with acute neuroborrel-
iosis (filied circles) and late Lyme encephalopathy (open circles).
Spearman rank correlation coefficients: rs = 0.871, p = 0.0026
(all patients, n = 13), rs = 0.743, p = 0.036 (only patients with
late Lyme encephalopathy, n = 9). Note logarithmic scale of ana-
lyte concentrations.
Neopterin was higher in patients (n = 14: 7.4 ± 2.2
nmol/l) than in the controls (n = 20: 5.2 ± 1.8 nmol/l;
U = 3.13, p = 0.0017). Interestingly, a correlation ex-
isted between serum and cerebrospinal fluid tryptophan
concentrations (rs = 0.714, p = 0.043) in the s bgroup
of patients with late Lyme erteephalopathy. Cerebrospi-
nal fluid concentrations of neopterin (U = 2.10;
p < 0.05) and kynurenine (U = 2.11; p < 0.05) were
higher in patients with acute Lyme neuroborreliosis
compared with those with late Lyme encephalopathy,
where s tryptophan concentrations did not differ. In se-
rum, no differences were found between patients with
acute Lyme neuroborreliosis and patients with late Lyme
encephalopathy.
Discussion
The data confirm and extend earlief results obtained in
patients with B. burdorferi infection (3, 4) and are con-
sistent with the view that degradation of tryptophan due
to immune activation was the reason for the accumula-
tion of L-kynurenine. Increased concentrations of
neopterin in cerebrospinal fluid indicate activation of
immunocompetent cells in the brain and indirectly con-
firm the endogenous formation of cytokines, such s in-
terferon-γ and tumour necrosis factor-α, in the patients,
because large ampunts of neopterin are released from
human monocytes/macrophages upon activation with in*
terferon-γ in vitro. Our data also demonstrate that signif-
icant degradation of tryptophan occurs in the cerebrospi-
nal fluid of patients with acute Lyme neuroborreliosis.
Thus, the increase of the tryptophan metabolite, kynure-
nine, correlates with the increase of neopterin. Impor-
tantly, kynurenine was even higher in patient 3, who
had an extremely low tryptophan concentration in the
cerebrospinal fluid (tab. 2). This observation can be ex-
plained by the strong activation of indoleamine (2,3)-
dioxygenase, s indicated by the very high kynurenine :
tryptophan ratio of 2000 in the same patient. Interest-
ingly, similar associations between the formation of
neopterin and kynurenine have also been demonstrated
in patients suffering from multiple sclerosis (13).
Changes of tryptophan metabolism possibly play role
in the pathogenesis of neurological Symptoms in pa-
tients. On the one hand, a decrease of tryptophan may
disturb serotonin metabolism (4); on the other hand
neurotoxic products of tryptophan degradation, like ky-
nurenic acid or quinolinic acid, may have a role (14).
One of our patients showed a severely decreased trypto-
phan level in cerebrospinal fluid, and serum tryptophan
levels tended to decrease in several patients of both -
groups, even when there was no detectable increase of
tryptophan metabolites in serum. It appears that, in the
chronic Situation, degradation of tryptophan in. cerebro-
EUF. J. Clin. Chem. Clin. Biochem. /Vol. 32,1994 /No. 9
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spinal fhiid may also contribute to the deficiency of
tryptophan in serum by causing a compensatory flux of
tryptophan into the brain. Interestingly, a significant as-
sociation between serum and cerebrospinal fluid trypto-
phan levels was found in the patients with late Lyme
encephalopathy (rs = 0.714, p = 0.05).
When comparing late Lyme encephalopathy with acute
Lyme neuroborreliosis, it is evident that metabolic
changes in cerebrospinal fluid are much more pro-
nounced in the latter group of patients. However, similar
correlations existed between the changes of tryptophan
metabolism and neopterin in late Lyme encephalopathy,
which suggests a low-level, on-going infection, at least
in some patients. This would lead to low-grade chronic
immune activation, with increased degradation of tryp-
tophan. In our patients with late Lyme encephalopathy,
however, we found no correlation between biochemical
changes and specific clinical Symptoms, such äs chronic
neurological manifestations. From this observation, it
appears that irreversible damage of brain tissue, particu-
larly during the acute phase of Lyme neuroborreliosis,
is the major determinant of late Symptoms in patients.
Further studies are needed to clarify this point.
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